Company Circio Holding ASA

Equities

TRVX

NO0013033795

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Circio Holding ASA

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-26 am EDT			5-day change	1st Jan Change
2.7 ^NOK	+0.75%		-6.90%	-62.50%

Apr. 25	Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 17	Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	MT

Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circioâs second clinical program is an immunotherapy targeting KRAS driver mutations.

Number of employees: 17

Managers	Title	Age	Since
Erik Digman Wiklund CEO	Chief Executive Officer	-	17-03-31
Lubor Gaal DFI	Director of Finance/CFO	56	22-03-06
Thomas Hansen CTO	Chief Tech/Sci/R&D Officer	-	21-12-31
Victor Levitsky CTO	Chief Tech/Sci/R&D Officer	-	20-05-03
Ola Melin COO	Chief Operating Officer	-	21-09-30

Members of the board	Title	Age	Since
Diane Mellett BRD	Director/Board Member	64	15-09-13
Thomas Falck BRD	Director/Board Member	58	22-04-20
Robert Forbes Burns BRD	Director/Board Member	77	15-06-30
Damian Marron CHM	Chairman	62	20-04-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	7,163,743	5,995,887 ( 83.70 %)	0	83.70 %

Name	Equities	%	Valuation
Høse AS 4.396 %	348,959	4.396 %	194 060 kr
Per Wold 2.305 %	183,017	2.305 %	101 778 kr
RADFORSK INVESTERINGSSTIFTELSE 1.859 %	147,574	1.859 %	82 067 kr
Pettersen Gruppen AS 1.528 %	121,335	1.528 %	67 476 kr
Ramsvik Frisør AS 1.260 %	99,999	1.260 %	55 610 kr
Vaktmestergruppen AS 0.9277 %	73,652	0.9277 %	40 959 kr
Martin Aage Thorendahl 0.8397 %	66,666	0.8397 %	37 074 kr
Ragnvald Gabrielsen AS 0.8212 %	65,196	0.8212 %	36 256 kr
GRANUM AS 0.6433 %	51,069	0.6433 %	28 400 kr
Eirik Lunde 0.6298 %	50,000	0.6298 %	27 806 kr

Circio Holding ASA

Vollsveien 19

1366, Lysaker

+47 21 39 88 10

http://www.targovax.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.7 NOK

Average target price

48 NOK

Spread / Average Target

+1,677.78%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
CIRCIO HOLDING ASA	-62.50%	1.86M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs